Riskpilot← Back to searchSign inGet full accessELAVIT FYSIOTERAPI AS
ASActiveOrg 915290698Solheimveien 28, 1461 LørenskogPhysiotherapy activities · NACE 8695Est. 20151 employeeselavit.no
Revenue 2024
NOK 2,6M
+66% vs 2023
EBITDA margin
25.3%
-8% vs 2023
Equity ratio
74.8%
Financial strength
Net profit 2024
NOK 363K
-28% vs 2023
| Revenue | NOK 2,6M | +66% |
| EBITDA | NOK 670K | -8% |
| Net profit | NOK 363K | -28% |
| Total assets | NOK 1,2M | -11% |
| Equity | NOK 888K | +69% |
| Employees | 1 | — |
Legal name
ELAVIT FYSIOTERAPI AS
Org number
915290698
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
23. april 2015
Share capital
NOK 80 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av helsesenter med tilhørende aktiviteter samt utleie av lokaler og andre produkter/tjenester som naturlig hører sammen med dette, samt å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Solheimveien 28, 1461 Lørenskog
Website
elavit.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1 591 | 2 645 |
| Staff expenses | −0 | −0 | −0 | −96 | −491 |
| EBITDA | −5 | −65 | −1 | 725 | 670 |
| Depreciation & amort. | −0 | −0 | −0 | −83 | −168 |
| EBIT | −5 | −65 | −1 | 642 | 501 |
| Net financials | 0 | 0 | 0 | −0 | −3 |
| Profit before tax | −5 | −65 | −1 | 642 | 498 |
| Tax | −1 | −14 | −0 | 141 | 135 |
| Net profit | −4 | −51 | −1 | 501 | 363 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 102 | 24 | 24 | 1 330 | 1 187 |
| Equity | 49 | −2 | −3 | 524 | 888 |
| Long-term debt | 0 | 0 | 0 | 15 | 47 |
| Short-term debt | 53 | 26 | 27 | 790 | 253 |
| Total debt | 53 | 26 | 27 | 805 | 300 |
EBITDA margin
25.3%
This company
15.8%
Market median
+60% vs market
20202024
Equity ratio
74.8%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
40.9%
This company
18.4%
Market median
+122% vs market
20202024
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
20202024
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2016 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 78.12% | 78.12% | 2022 | |
| Individual | 21.88% | 21.88% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ELAVIT FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristoffer Sangvik-Jebsen | Chief Executive Officer | 0 companies |
| Ola Skjeseth | Chairman | 0 companies |
| Tom Vian Engen | Chairman | 0 companies |